Form D · Pharmaceuticals
Madison Vaccines Inc
Madison, WI · CIK 0001598692
Offering snapshot reported Jan 31, 2014 · SEC filing
- Reported sold
- $2.41M Offering amount: $9.03M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 31, 2014 | Initial | $2,406,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-211088
Source: Form D, filed Jan 31, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leigh Cagan | Director |
| Richard R. Lesniewski, Ph D | Director, Executive |
| Douglas G. Mc Neel, Md, Ph D | Director, Executive |
| Paul Weiss, Ph D | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
505 South Rosa Road, Suite 201
Madison, WI, 53719
Madison, WI, 53719